Shaw LM - Search Results

1

Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers.

Hilaire MR, Gill RV, Courtney JB, Baburina I, Gardiner J, Milone MC, Shaw LM, Meng QH, Salamone SJ. Hilaire MR, et al. Among authors: shaw lm. Ther Drug Monit. 2021 Dec 1;43(6):766-771. doi: 10.1097/FTD.0000000000000883. Ther Drug Monit. 2021. PMID: 33814542 Free PMC article.

2

Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose.

Yuan CM, Spandorfer PR, Miller SL, Henretig FM, Shaw LM. Yuan CM, et al. Among authors: shaw lm. Ther Drug Monit. 2003 Jun;25(3):299-304. doi: 10.1097/00007691-200306000-00009. Ther Drug Monit. 2003. PMID: 12766557

3

Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.

Solari SG, Goldberg LR, DeNofrio D, Shaw LM. Solari SG, et al. Among authors: shaw lm. Ther Drug Monit. 2005 Aug;27(4):417-21. doi: 10.1097/01.ftd.0000159786.10625.85. Ther Drug Monit. 2005. PMID: 16044096 Clinical Trial.

4

Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement.

Korecka M, Solari SG, Shaw LM. Korecka M, et al. Among authors: shaw lm. Ther Drug Monit. 2006 Aug;28(4):484-90. doi: 10.1097/00007691-200608000-00002. Ther Drug Monit. 2006. PMID: 16885715

5

Therapeutic drug monitoring of mycophenolic acid.

Shaw LM, Figurski M, Milone MC, Trofe J, Bloom RD. Shaw LM, et al. Clin J Am Soc Nephrol. 2007 Sep;2(5):1062-72. doi: 10.2215/CJN.03861106. Epub 2007 Aug 16. Clin J Am Soc Nephrol. 2007. PMID: 17702714 Review. No abstract available.

6

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.

Figurski MJ, Nawrocki A, Pescovitz MD, Bouw R, Shaw LM. Figurski MJ, et al. Among authors: shaw lm. Ther Drug Monit. 2008 Aug;30(4):445-55. doi: 10.1097/FTD.0b013e318180c986. Ther Drug Monit. 2008. PMID: 18641543

7

Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.

Brandhorst G, Marquet P, Shaw LM, Liebisch G, Schmitz G, Coffing MJ, Domke I, Streit F, Luthe H, Oellerich M. Brandhorst G, et al. Among authors: shaw lm. Ther Drug Monit. 2008 Aug;30(4):428-33. doi: 10.1097/FTD.0b013e31817fd590. Ther Drug Monit. 2008. PMID: 18641549

8

Effect of a variable magnetic field on clinical laboratory testing.

Kricka LJ, Milone M, Master SR, Shaw LM, Young DS, Fontanilla R, Smith T, Gardiner J, Cardamone D, Fleming M, Rhoads DG. Kricka LJ, et al. Among authors: shaw lm. Clin Chem. 2009 Jun;55(6):1249-50. doi: 10.1373/clinchem.2009.123679. Epub 2009 Apr 2. Clin Chem. 2009. PMID: 19342500 No abstract available.

9

High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.

Figurski MJ, Korecka M, Fields L, Waligórska T, Shaw LM. Figurski MJ, et al. Among authors: shaw lm. Ther Drug Monit. 2009 Dec;31(6):717-26. doi: 10.1097/FTD.0b013e3181ba9a0e. Ther Drug Monit. 2009. PMID: 19809389

10

Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.

Korecka MA, Patel R, Shaw LM. Korecka MA, et al. Among authors: shaw lm. Ther Drug Monit. 2011 Aug;33(4):460-3. doi: 10.1097/IAE.0b013e3182219af8. Ther Drug Monit. 2011. PMID: 21743385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

725 results

Search Page